Liver Mass Case Mimicked Cancer Diagnosis
A new case report documents a patient whose liver masses appeared to be malignant but proved benign.
Updated on Oct. 14, 2026 in Cancer
Medical professionals have documented a rare instance where a patient presented with liver masses and lymph node enlargement that mirrored the appearance of cancer. A biopsy later confirmed the lesions were an inflammatory pseudotumor rather than a malignancy.
Why it matters
Diagnostic imaging can occasionally misidentify benign inflammatory masses as spreading cancer, posing challenges for clinical treatment plans. Accurate diagnosis requires histopathology to distinguish these pseudotumors from potentially life-threatening malignancies.
A 39-year-old patient presented with liver masses measuring up to 15 by 5 by 14 centimeters. While imaging initially suggested peritoneal carcinomatosis, histopathology confirmed a proliferation of inflammatory cells.
The players
Avicenne Hospital
This is a medical facility located in Rabat, Morocco, where the patient was treated.
Oxford Medical Case Reports
This is a peer-reviewed academic journal that publishes case reports across the spectrum of medical research.
The details
The patient presented with irregular liver masses and abdominal nodules, but blood tests showed only moderately raised liver enzymes. A CT-guided needle biopsy of the lesion enabled the identification of scar-forming fibroblasts and myofibroblasts, which are characteristic of inflammatory pseudotumors.
Timeline
A study of 45 patients with this condition took place from 1995 to 2011.
A review describing the condition as rare was published in 2011.
The case report was published in Oxford Medical Case Reports on October 4, 2026.
Health Landscape
This case report adds to the clinical literature established by the 2011 multicenter study of 45 patients with hepatic pseudotumor. Such reports help clinicians refine diagnostic accuracy when imaging results mimic the appearance of metastatic cancer.
Patients presenting with abdominal masses should be aware that initial imaging findings are not always definitive for cancer. Histopathological biopsy remains the gold standard for confirming a diagnosis and ensuring that treatment plans are appropriate for the specific tissue pathology.
The takeaway
This case illustrates the importance of using invasive tissue sampling to verify imaging results when liver masses appear atypical. Clinicians should maintain a broad differential diagnosis even when initial evidence strongly points toward malignancy.
Further reading
For more information on the complexities of oncology diagnostics, visit the Cancer section.
Source note: This article includes information reported by Medical Daily.
